iShares Evolved U.S. Innovative Healthcare ETF
Health/Biotechnology
IEIH
400 HOWARD STREET,
SAN FRANCISCO , CA, 94105
SAN FRANCISCO , CA, 94105
Price
-
$ 34.14
0 %
+0
Aug 29, 2022
- Last Close
- Net Assets
-
$36.8M
Sep 27, 2022
- 52-Week High/Low
- $37.61 - $30.11
- Expense Ratio
- -
Link
Directors
Oct 13, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Aaron Wasserman
Company Name |
Holding |
| More | 0.08 % |
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | - | - | -3.4% | -81.2% | -9.3% | 10.8% |
| Q2 | - | - | -3.9% | 20.1% | 18.2% | -1.9% |
| Q3 | - | - | 3.7% | -4.2% | -19.6% | -5.8% |
| Q4 | - | - | - | 4.5% | 231% | 15.4% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | - | - | - | - | - | - | - | - | - | - | - | - |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | -3.7% | -55.5% | 185.1% | 19% | 0% | 67.7% | -6.5% | 1% | -18.4% |